Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55

Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $338.55, but opened at $281.55. Bio-Rad Laboratories shares last traded at $279.91, with a volume of 400 shares trading hands.

Bio-Rad Laboratories Stock Performance

The business has a 50-day moving average price of $316.96 and a two-hundred day moving average price of $313.90. The company has a market cap of $7.98 billion, a P/E ratio of -13.03 and a beta of 0.70. The company has a quick ratio of 4.34, a current ratio of 5.83 and a debt-to-equity ratio of 0.14.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The company reported $3.10 earnings per share (EPS) for the quarter. The firm had revenue of $681.18 million for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%.

About Bio-Rad Laboratories

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Read More

Should you invest $1,000 in Bio-Rad Laboratories right now?

Before you consider Bio-Rad Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.

While Bio-Rad Laboratories currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

Search Headlines: